Find a Tender
complete
Official procurement procedure
BCU-FTS-59576 CELLULAR PATHOLOGY REAGENT DELIVERY AND COLLECTION
No classification published
Location not published
Published value
£150,000
Submission deadline 10 Apr 2026, 12:00 BST
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Betsi Cadwaladr University Health Board: "BCU-FTS-59576 CELLULAR PATHOLOGY REAGENT DELIVERY AND COLLECTION". Published status: complete. Published value: £150,000. 1 published lot. Recorded submission deadline: 10 Apr 2026, 12:00 BST. See the official notice for participation instructions.
| Contracting Authority | Betsi Cadwaladr University Health Board | Scope & Categories | Not published | Submission Window | Closed 10 Apr 2026, 12:00 BST |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £150,000 |
Bidder Intelligence · Authority Profile: Betsi Cadwaladr University Health Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Betsi Cadwaladr University Health Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.5Bids / Report
Supplier ConcentrationHigh Concentration
ASV ResearchTop vendor: 77.7% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 6 active published awards; 2 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| ASV Research | 1 win | £82,000 |
| Kitchequip | 1 win | £23,470 |
Procedure terms
Contracting AuthorityBetsi Cadwaladr University Health Board | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published25 Jun 2026, 15:43 BST | Last source update25 Jun 2026, 15:43 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-0585e0 | ||
What is being bought
Betsi Cadwaladr University Health Board (BCUHB) Cellular Pathology routinely uses substantial volumes of Formalin, Xylene, and other specialised reagents in the histological preparation and analysis of tissue specimens. These reagents are critical in investigating a broad spectrum of conditions, including malignant and benign tumours, as well as other tissue and cellular abnormalities, to enable accurate diagnosis and guide targeted treatment pathways.
BCUHB seeks to appoint a suitably qualified supplier capable of delivering a reliable and timely supply of these reagents, alongside a dedicated service for the safe collection and compliant disposal of associated chemical waste. This will ensure uninterrupted laboratory operations, full regulatory compliance, and continuity of service.
What changed
From the official release history
- tender value changed
25 Jun 2026, 15:43 BST - Status changed to complete
25 Jun 2026, 15:43 BST - Official notice release published
25 Jun 2026, 15:43 BST - Submission deadline changed to published date
25 Jun 2026, 15:43 BST - Status changed to active
25 Feb 2026, 12:01 GMT - Official notice release published
25 Feb 2026, 12:01 GMT - Submission deadline changed to 10 Apr 2026, 12:00 BST
25 Feb 2026, 12:01 GMT - Buyer information updated
25 Feb 2026, 12:01 GMT - Published value updated to £150,000
12 Aug 2025, 11:29 BST - Status changed to planning
12 Aug 2025, 11:29 BST - Official notice release published
12 Aug 2025, 11:29 BST - Buyer information updated
12 Aug 2025, 11:29 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
25 Jun 2026, 15:43 BST - Submission deadline
10 Apr 2026, 12:00 BST - Award pending
25 Jun 2026, 00:00 BST · £175,000
Commercial outcome and competition
Awards Cell Path Ltd £175,000 · 25 Jun 2026, 00:00 BST · pending |
ContractsNo contract published |
Bid statistics bids: 1 (lot 1) finalStageBids: 1 (lot 1) smeFinalStageBids: 1 (lot 1) vcseFinalStageBids: 0 (lot 1) |
Buyer and organisations in this procedure
Betsi Cadwaladr University Health Board
Contracting authority GB-PPON-PHBY-3981-QBMRAward and contract changes
Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published